Evaxion Biotech A/S (EVAX) News Today $1.37 -0.03 (-2.14%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Evaxion Biotech files to sell 5.25M American Depositary SharesNovember 19 at 6:15 AM | markets.businessinsider.comEvaxion appeals Nasdaq delisting determinationNovember 15, 2024 | uk.investing.comEvaxion Biotech A/S (NASDAQ:EVAX) Sees Significant Decrease in Short InterestNovember 15, 2024 | americanbankingnews.comEvaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listingNovember 13, 2024 | finance.yahoo.comEvaxion Biotech: Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listingNovember 13, 2024 | finanznachrichten.deEvaxion Biotech receives, appeals delisting determination from NasdaqNovember 13, 2024 | markets.businessinsider.comEvaxion Biotech Appeals Nasdaq Delisting DecisionNovember 13, 2024 | markets.businessinsider.comEvaxion Biotech announces preclinical data for CMV vaccine program EVX-V1November 13, 2024 | markets.businessinsider.comEvaxion Biotech: Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1November 12, 2024 | finanznachrichten.deEvaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1November 12, 2024 | globenewswire.comCardiol Therapeutics (NASDAQ:CRDL) versus Evaxion Biotech A/S (NASDAQ:EVAX) Financial ContrastNovember 11, 2024 | americanbankingnews.comEvaxion Biotech Shows Progress Amid Nasdaq ChallengesNovember 2, 2024 | markets.businessinsider.comEvaxion Biotech Reports Q3 Progress and FinancialsNovember 1, 2024 | markets.businessinsider.comEvaxion announces business update and third quarter 2024 financial resultsOctober 31, 2024 | globenewswire.comEvaxion Biotech to Announce Q3 Financial ResultsOctober 29, 2024 | markets.businessinsider.comEvaxion to announce business update and third quarter 2024 financial results on October 31October 28, 2024 | globenewswire.comEvaxion Biotech Validates AI-Powered Vaccine PredictionsOctober 15, 2024 | msn.comNewly discovered COVID vaccine targets may last longerOctober 11, 2024 | msn.comOTC Markets Hosts Virtual Investor Presentation with Christian Kanstrup, CEO of Evaxion Biotech, and Brad Sorensen, Senior Analyst at Zacks SCROctober 11, 2024 | msn.comStrong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trialsOctober 9, 2024 | markets.businessinsider.comStrong validation of Evaxion's AI-Immunology™ platform in multiple clinical trialsOctober 9, 2024 | globenewswire.comClinical Evidence Supports Advancement of Evaxion's AI-Immunology PlatformOctober 5, 2024 | msn.comEvaxion Biotech Charts Future with Innovative Immune TherapiesOctober 4, 2024 | finance.yahoo.comEvaxion Biotech: Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology platformOctober 3, 2024 | finanznachrichten.deRecent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platformOctober 3, 2024 | globenewswire.comEvaxion Biotech (EVAX) Gets a Buy from Lake StreetSeptember 27, 2024 | markets.businessinsider.comEvaxion significantly expands vaccine development collaboration with MSDSeptember 26, 2024 | globenewswire.comEvaxion Biotech enhances AI vaccine discovery platformSeptember 21, 2024 | uk.investing.comEvaxion Biotech Unveils Enhanced AI Platform for Improved Vaccine DevelopmentSeptember 21, 2024 | msn.comLife Sciences Virtual Investor Forum Presentations Now Available for Online ViewingSeptember 20, 2024 | finance.yahoo.comBuy Rating for Evaxion Biotech Supported by Strong Clinical Results and PIONEER Platform’s PotentialSeptember 20, 2024 | markets.businessinsider.comEvaxion launches improved AI-Immunology™ platform for vaccine antigen predictionSeptember 19, 2024 | globenewswire.comEvaxion Biotech Reports Positive One-Year Results for AI-Designed Cancer VaccineSeptember 18, 2024 | msn.comEvaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01September 16, 2024 | markets.businessinsider.comEvaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01September 9, 2024 | markets.businessinsider.comEvaxion Biotech: Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2September 9, 2024 | finanznachrichten.deEvaxion Biotech: Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01September 9, 2024 | finanznachrichten.deEvaxion Biotech: Clinical Phase 2 Data Supports Clinical Profile Of EVX-01September 9, 2024 | markets.businessinsider.comEvaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2September 9, 2024 | globenewswire.comEvaxion Biotech A/S (NASDAQ:EVAX): Is Breakeven Near?August 30, 2024 | finance.yahoo.comBuy Rating Affirmed for Evaxion Biotech on Strong Financials and Promising Clinical TrialsAugust 16, 2024 | markets.businessinsider.comEarnings To Watch: Home Depot (HD) Reports Q2 Results TomorrowAugust 12, 2024 | uk.finance.yahoo.comEvaxion Biotech: Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14August 12, 2024 | finanznachrichten.deEvaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14August 12, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday TradingAugust 8, 2024 | msn.comEvaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in SeptemberAugust 8, 2024 | globenewswire.comBuy Rating for Evaxion Biotech: EVX-01’s Personalized Cancer Vaccine Shows Promising Efficacy and SafetyAugust 1, 2024 | markets.businessinsider.comBiotech company's CEO pleads guilty in Mississippi welfare fraud caseJuly 26, 2024 | msn.comEQS-Adhoc: BB Biotech AG publishes its interim report and announces a new head of its investment management teamJuly 26, 2024 | markets.businessinsider.comEvaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology ConferenceJuly 16, 2024 | globenewswire.com Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. EVAX Media Mentions By Week EVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVAX News Sentiment▼0.160.47▲Average Medical News Sentiment EVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVAX Articles This Week▼32▲EVAX Articles Average Week Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Surrozen News Today SAB Biotherapeutics News Today MiNK Therapeutics News Today Pluri News Today Athira Pharma News Today Curis News Today Calidi Biotherapeutics News Today Cyclo Therapeutics News Today Finch Therapeutics Group News Today Cognition Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVAX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVAX Stock Alerts